Works matching IS 03407004 AND DT 2006 AND VI 55 AND IP 4

Results: 14

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 433, doi. 10.1007/s00262-005-0025-6

By:

Alexander, A. N.;
Huelsmeyer, M. K.;
Mitzey, Ann;
Dubielzig, R. R.;
Kurzman, I. D.;
MacEwen, E. G.;
Vail, D. M.

Publication type:

Article

Importance of signaling via the IFN-α/β receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 459, doi. 10.1007/s00262-005-0029-2

By:

Mokyr, Margalit B.;
Place, Aaron T.;
Artwohl, James E.;
Valli, VE Ted

Publication type:

Article

Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 375, doi. 10.1007/s00262-005-0011-z

By:

Su-Ping Ren;
Chu-Tse Wu;
Wen-Rong Huang;
Zhuo-Zhuang Lu;
Xiang-Xu Jia;
Lan Wang;
Miao-Fen Lao;
Li-Sheng Wang

Publication type:

Article

Structure and function of ETAA16: a novel cell surface antigen in Ewing’s tumours.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 363, doi. 10.1007/s00262-005-0017-6

By:

Borowski, A.;
Dirksen, U.;
Lixin, L.;
Shi, R. L.;
Göbel, U.;
Schneider, E. M.

Publication type:

Article

Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 420, doi. 10.1007/s00262-005-0006-9

By:

Gatza, Erin;
Okada, Craig

Publication type:

Article

Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 451, doi. 10.1007/s00262-005-0018-5

By:

Haanen, J.;
Baars, A.;
Gomez, R.;
Weder, P.;
Smits, M.;
Gruijl, T.;
Blomberg, B.;
Bloemena, E.;
Scheper, R.;
Ham, S.;
Pinedo, H.;
Eertwegh, A.

Publication type:

Article

Interferon-α/β upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-α/β treatment.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 394, doi. 10.1007/s00262-005-0005-x

By:

Yamaji, Kouzaburo;
Nabeshima, Shigeki;
Murata, Masayuki;
Chong, Yong;
Furusyo, Norihiro;
Ikematsu, Hideyuki;
Hayashi, Jun

Publication type:

Article

Efficacy of adjuvant Immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 404, doi. 10.1007/s00262-005-0054-1

By:

Sakamoto, Junichi;
Morita, Satoshi;
Oba, Koji;
Matsui, Takanori;
Kobayashi, Michiya;
Nakazato, Hiroaki;
Ohashi, Yasuo

Publication type:

Article

A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8<sup>+</sup> T cell responses against NA17-A2 tumor peptide in melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 469, doi. 10.1007/s00262-005-0056-z

By:

Trakatelli, Myrto;
Toungouz, Michel;
Blocklet, Didier;
Dodoo, Ygierne;
Gordower, Laurence;
Laporte, Marianne;
Vereecken, Pierre;
Sales, Francois;
Mortier, Laurent;
Mazouz, Naima;
Lambermont, Micheline;
Goldman, Serge;
Coulie, Pierre;
Goldman, Michel;
Velu, Thierry

Publication type:

Article

Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 412, doi. 10.1007/s00262-005-0013-x

By:

Johnston, Dean;
Reynolds, Sandra;
Bystryn, Jean-Claude

Publication type:

Article

Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 355, doi. 10.1007/s00262-005-0081-y

By:

Tamada, Koji;
Lieping Chen

Publication type:

Article

Cancer Immunotherapy 2005: Mainz, Germany, 12–13 May 2005.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 475, doi. 10.1007/s00262-005-0059-9

By:

Britten, C.;
Gouttefangeas, C.;
Kreiter, S.

Publication type:

Article

Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 443, doi. 10.1007/s00262-005-0041-6

By:

Leòn, Joel;
Fernández, Audry;
Mesa, Circe;
Clavel, Marilyn;
Fernández, Luis

Publication type:

Article

Human T lymphocyte responses against lung cancer induced by recombinant truncated mouse EGFR.

Published in:

Cancer Immunology, Immunotherapy, 2006, v. 55, n. 4, p. 386, doi. 10.1007/s00262-005-0028-3

By:

Bing Hu;
Yu-Quan Wei;
Ling Tian;
Xia Zhao;
You Lu;
Yang Wu;
Bing Yao;
Xiao-Wei Zhang

Publication type:

Article